Search
Searching Content indexed under Healthcare by Stikeman Elliott LLP ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
Operationalizing Health Canada's Authority To Assess Medical Devices Post-Approval: The Latest On The Regulatory Consultation Process
In 2014, amendments to the Food and Drugs Act gave the federal Minister of Health authority with respect to the safety of drugs, medical devices and other therapeutic devices that are already
Canada
9 Jul 2019
2
Mise en œuvre du pouvoir qu'a Santé Canada d'évaluer les instruments médicaux après leur approbation : Le point sur le processus de consultation réglementaire
En 2014, des modifications apportées à la Loi sur les aliments et drogues ont conféré au ministre fédéral de la Santé le pouvoir de régir la sûreté des médicaments, des instruments médicaux et des autres appareils thérapeutiques qui sont déjà sur le marché.
Canada
5 Jul 2019
3
Canada
16 Nov 2018
4
Competition Bureau Questions: Why Don't We See More Health Care Advertising?
On October 4, 2016, the Competition Bureau published a report assessing the effect of advertising restrictions on the health care marketplace.
Canada
26 Oct 2016
5
Competition Bureau Questions: Why Don't We See More Health Care Advertising?
Due to regulations by provincial governments and professional bodies, Canadian health care professionals face significant restrictions on how they are permitted to advertise their services in the marketplace.
Canada
21 Oct 2016
6
U.S. President Vetoes H.R. 3762 Which Would Have Repealed Certain Tax Provisions Of Obamacare
On January 6, 2016, the House of Representatives, by a vote of 240 to 181, approved the Senate-passed legislation, Restoring American Healthcare Freedom Reconciliation Act of 2015, that we previously reported about.
United States
13 Jan 2016
7
Quebec Employers Can Now Challenge The CSST Statements Of Imputed Costs
Pursuant to the Act Respecting Industrial Accidents and Occupational Diseases, an employer may, within 30 days of notification of the decision, apply for review thereof.
Canada
3 Aug 2015
8
Snoops And Gossips Beware: Ontario Government To Introduce Stiffer Measures To Protect Patient Privacy
Recently, the Government of Ontario announced its intent to strengthen the rules protecting patient privacy.
Canada
7 Jul 2015
9
Senate Committee Releases Final Report On Prescription Pharmaceuticals In Canada
On March 10, 2015, the Standing Senate Committee on Social Affairs, Science and Technology released a final report entitled "Prescription Pharmaceuticals in Canada".
Canada
15 Apr 2015
10
Certification Granted In Proposed eHealth Ontario Performance Awards Class Action
The plaintiff employees in the high-profile eHealth Ontario ("eHealth") class action Perrenoud v. eHealth Ontario have cleared the certification hurdle for three of four claims brought against eHealth and Her Majesty the Queen in Right of Ontario ("Ontario") as a result of eHealth’s decision last year to suspend its Performance Incentive Policy and cancel the employees’ performance awards and merit increases for fiscal years 2010/11 and 2011/12.
Canada
27 Dec 2012
11
Federal Court Of Appeal Upholds The Data Protection Regulations And Its Guaranteed Eight-Year Period Of Market Exclusivity For "Innovative Drugs"
The Federal Court of Appeal has upheld the validity of section 30(3) of the Food and Drugs Act and section C.08.004.1 of the Food and Drug Regulations (known as the Data Protection Regulations) in its decision in Apotex Inc. v. The Minister of Health, 2010 FCA 334.
Canada
1 Feb 2011
12
Amendments To Alberta's Health Information Act Come Into Force On September 1, 2010
Recent amendments to Alberta’s Health Information Act, and related regulations, come into force on September 1, 2010.
Canada
8 Sep 2010
13
Amendments To The Patented Medicines (Notice Of Compliance) Regulations And Food And Drug Regulations
On October 5, 2006, the government of Canada passed substantive amendments to the Patented Medicines (Notice of Compliance) Regulations (the PM(NOC) Regulations) and the data protection provisions of the Food and Drug Regulations (the FD Regulations).
Canada
30 Nov 2006
14
Products Liability In Flux: Courts Continue To Struggle With The Doctrine Of Waiver Of Tort
Back in the summer of 2004, Mr. Justice Cullity of the Ontario Superior Court of Justice granted certification of a class action on behalf of users of a certain type of blood glucose monitor, which was alleged to be "dangerously defective" but which appeared to cause no harm: Serhan v. Johnson & Johnson (2004), 72 O.R. (3d) 296 (S.C.J.).
Canada
10 Oct 2006
Links to Result pages
 
1